Загрузка...
Monoclonal Antibodies for Systemic Lupus Erythematosus (SLE) †
A number of monoclonal antibodies (mAb) are now under investigation in clinical trials to assess their potential role in Systemic Lupus Erythematosus (SLE). The most frequently used mAb is rituximab, which is directed against CD20, a membrane protein expressed on B lymphocytes. Uncontrolled trials r...
Сохранить в:
| Главные авторы: | , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Molecular Diversity Preservation International
2010
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3991031/ https://ncbi.nlm.nih.gov/pubmed/27713252 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ph3010300 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|